Working to Eradicate Gynecologic Cancers

191
Antitumor activity of the ribonucleotide reductase inhibitor triapine alone or in combination with paclitaxel

Saturday, March 28, 2015: 9:55 AM
Salon C-D (Hilton Chicago)
K. Ishiguro, Z. P. Lin, T. J. Rutherford and E. S. Ratner
Yale University School of Medicine, New Haven, CT